Hematology/Oncology, Long Island Jewish Medical Center Northwell Health Cancer Institute, New Hyde Park, New York, USA
Hematology/Oncology, Long Island Jewish Medical Center Northwell Health Cancer Institute, Lake Success, New York, USA.
BMJ Case Rep. 2021 Jul 30;14(7):e242678. doi: 10.1136/bcr-2021-242678.
A 26-year-old woman was sent to the emergency room by her primary care physician for a new petechial rash and thrombocytopenia 2 weeks after receiving the Moderna mRNA-1273 SARS-CoV-2 vaccine. Her hospital course was complicated by transaminitis. Her platelet count improved to normal on hospital day 5 after receiving intravenous steroids and intravenous immunoglobulin to treat her suspected diagnosis of immune thrombocytopenic purpura. Extensive workup for her thrombocytopenia and transaminitis was unremarkable including ruling out infectious, autoimmune and toxic causes. A liver biopsy was unrevealing and her transaminitis was improved on discharge. Although not proven, the temporal relationship of her vaccination with thrombocytopenia and abnormal liver enzymes points towards the Moderna mRNA-1273 SARS-CoV-2 vaccine as the most likely inciting factor.
一位 26 岁女性因新出现瘀点性皮疹和血小板减少,在接受 Moderna mRNA-1273 SARS-CoV-2 疫苗接种后 2 周,由初级保健医生转至急诊室。她的住院过程因肝氨基转移酶升高而变得复杂。在接受静脉注射类固醇和静脉注射免疫球蛋白治疗疑似免疫性血小板减少性紫癜后,她的血小板计数在住院第 5 天恢复正常。对她的血小板减少症和肝氨基转移酶升高进行了广泛的检查,包括排除感染、自身免疫和中毒原因,但均无明显异常。肝活检无异常发现,出院时肝氨基转移酶升高情况有所改善。虽然尚未证实,但她接种疫苗与血小板减少症和异常肝酶之间的时间关系表明,最有可能的诱发因素是 Moderna mRNA-1273 SARS-CoV-2 疫苗。